SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-23-249135
Filing Date
2023-10-02
Accepted
2023-10-02 16:44:00
Documents
4
Period of Report
2023-10-02

Document Format Files

Seq Description Document Type Size
1 PREM14A d554900dprem14a.htm PREM14A 449227
2 EX-FILING FEES d554900dexfilingfees.htm EX-FILING FEES 15841
3 GRAPHIC g554900g11a11.jpg GRAPHIC 199355
4 GRAPHIC g554900g12a12.jpg GRAPHIC 188256
  Complete submission text file 0001193125-23-249135.txt   1000043
Mailing Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-40499 | Film No.: 231300301
SIC: 2834 Pharmaceutical Preparations